You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • FRI0021 Alx-0061, an anti-IL-6r nanobody® for therapeutic use in rheumatoid arthritis, demonstrates in vitro a differential biological activity profile as compared to tocilizumab

Citation Tools

Article menu
Download PDFPDF
Poster Presentation
Cytokines and inflammatory mediators
FRI0021 Alx-0061, an anti-IL-6r nanobody® for therapeutic use in rheumatoid arthritis, demonstrates in vitro a differential biological activity profile as compared to tocilizumab

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Van Roy M, Van de Sompel A, De Smet K, et al
FRI0021 Alx-0061, an anti-IL-6r nanobody® for therapeutic use in rheumatoid arthritis, demonstrates in vitro a differential biological activity profile as compared to tocilizumab
Annals of the Rheumatic Diseases 2013;72:A375.